176 related articles for article (PubMed ID: 10699920)
1. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis.
Takata M; Morita R; Takehara K
Int J Cancer; 2000 Feb; 85(4):492-7. PubMed ID: 10699920
[TBL] [Abstract][Full Text] [Related]
2. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
4. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression.
Morita R; Fujimoto A; Hatta N; Takehara K; Takata M
J Invest Dermatol; 1998 Dec; 111(6):919-24. PubMed ID: 9856796
[TBL] [Abstract][Full Text] [Related]
5. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of allelic deletions within melanoma metastases.
Bogdan I; Xin H; Burg G; Böni R
Melanoma Res; 2001 Aug; 11(4):349-54. PubMed ID: 11479423
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation.
Böni R; Matt D; Voetmeyer A; Burg G; Zhuang Z
J Invest Dermatol; 1998 Mar; 110(3):215-7. PubMed ID: 9506438
[TBL] [Abstract][Full Text] [Related]
8. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
9. Genotypic analysis of primary and metastatic cutaneous melanoma.
Rao UN; Jones MW; Finkelstein SD
Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
[TBL] [Abstract][Full Text] [Related]
11. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
[TBL] [Abstract][Full Text] [Related]
12. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma.
Katona TM; Jones TD; Wang M; Eble JN; Billings SD; Cheng L
Am J Surg Pathol; 2007 Jul; 31(7):1029-37. PubMed ID: 17592269
[TBL] [Abstract][Full Text] [Related]
13. Spitz nevi display allelic deletions.
Bogdan I; Burg G; Böni R
Arch Dermatol; 2001 Nov; 137(11):1417-20. PubMed ID: 11708943
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in sporadic primary cutaneous melanoma.
Healy E; Rehman I; Angus B; Rees JL
Genes Chromosomes Cancer; 1995 Feb; 12(2):152-6. PubMed ID: 7535089
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of allelic losses in primary melanoma.
Healy E; Belgaid C; Takata M; Harrison D; Zhu NW; Burd DA; Rigby HS; Matthews JN; Rees JL
Oncogene; 1998 Apr; 16(17):2213-8. PubMed ID: 9619830
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of LOH on chromosome 9 in sporadic primary melanomas is associated with increased patient age at diagnosis.
Smeds J; Kumar R; Rozell BL; Hemminki K
Mutagenesis; 2000 May; 15(3):257-60. PubMed ID: 10792020
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
18. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
19. 11q23 allelic loss is associated with regional lymph node metastasis in melanoma.
Herbst RA; Mommert S; Casper U; Podewski EK; Kiehl P; Kapp A; Weiss J
Clin Cancer Res; 2000 Aug; 6(8):3222-7. PubMed ID: 10955807
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
Zainuddin N; Jaafart H; Isa MN; Abdullah JM
Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
